| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 484 | 436 | 370 | 259 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 484 | 436 | 370 | 259 | | | Operating Expenses | | Research Development | 2,704 | 2,553 | 2,611 | 3,718 | | Selling General and Administrative | 1,189 | 1,286 | 1,453 | 1,371 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 58 | 58 | 59 | 60 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,467) | (3,461) | (3,753) | (4,890) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 89 | 114 | 128 | 179 | | Earnings Before Interest And Taxes | (3,378) | (3,347) | (3,625) | (4,712) | | Interest Expense | 2 |
-
|
-
| 1 | | Income Before Tax | (3,380) | (3,347) | (3,625) | (4,713) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,380) | (3,347) | (3,625) | (4,713) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,380) | (3,347) | (3,625) | (4,713) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,380) | ($3,347) | ($3,625) | ($4,713) |
|
0.51% Nasdaq 
Income Statement
